Leaps by Bayer
We are pleased to announce our license agreement for MaxCyte with CRISPR @CRISPRTX @MaxCyte_info — Casebia Therapeutics (@casebiatx) March 15, 2017
We are pleased to announce our license agreement for MaxCyte with CRISPR @CRISPRTX @MaxCyte_info
Leaps by Bayer uses cookies to enhance your experience of our site. By continuing to browse you consent to our use of cookies. More Information